96 related articles for article (PubMed ID: 2351854)
1. [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].
Okino T; Kan N; Mise K; Nakanishi M; Satoh K; Yamasaki S; Teramura Y; Inoue K; Ohgaki K; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):613-20. PubMed ID: 2351854
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of gastric cancer].
Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771
[TBL] [Abstract][Full Text] [Related]
4. [Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes].
Kan N; Okino T; Nakanishi M; Satou K; Mise K; Ohgaki K; Hori T; Kodama H; Tobe T
Hum Cell; 1988 Sep; 1(3):289-96. PubMed ID: 2979206
[TBL] [Abstract][Full Text] [Related]
5. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
[TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of LAK cell adoptive immunotherapy in advanced cancer patients].
Toge T; Takayama T; Kegoya Y; Kuninobu H; Yamaguchi Y; Hattori T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1455-8. PubMed ID: 2586438
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
Ohwada S; Takeshita M; Miyamoto Y; Izumi M
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1560-6. PubMed ID: 2263239
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
9. OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancer.
Mise K; Kan N; Okino T; Moriguchi Y; Harada T; Ichinose Y; Inoue K
Surg Today; 1994; 24(1):54-8. PubMed ID: 8054776
[TBL] [Abstract][Full Text] [Related]
10. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancers.
Satoh K; Kan N; Okino T; Mise K; Yamasaki S; Harada T; Hori T; Ohgaki K; Tobe T
Biotherapy; 1993; 6(1):41-9. PubMed ID: 8507544
[TBL] [Abstract][Full Text] [Related]
12. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
[TBL] [Abstract][Full Text] [Related]
13. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
[TBL] [Abstract][Full Text] [Related]
14. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
Kawata H
Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
[TBL] [Abstract][Full Text] [Related]
16. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
Yoshizawa H; Chang AE; Shu S
J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072
[TBL] [Abstract][Full Text] [Related]
17. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
18. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
Morikawa Y; Watanabe S; Kodama T
Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
Izumi M
Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
[TBL] [Abstract][Full Text] [Related]
20. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]